Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene

Gene Therapy

Volumn 4, Issue 8, 1997, Pages 868-874

  Kobinger, G P ^a   Mouland, A J ^a   Lalonde, J P ^a   Forget, J ^a   Cohen, E A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Packaging cell line; Retroviral production; Vpu

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VPU PROTEIN;

ARTICLE; CELL LINE; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS GENE; VIRUS PARTICLE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 0030845846     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300452     Document Type: Article

References (30)

1. Crystal RG. Transfer of genes to humans, early lessons and obstacles to success. Science 1995; 270: 404-410
2. Salmons B, Gunzburg WH. Targeting of retroviral vectors for gene therapy. Hum Gene Ther 1993; 4: 129-141.
3. Gordon EM, Anderson WF. Gene therapy using retroviral vectors. Curr Opin Biotechnol 1994; 5: 611-616.
4. Goff SP. Integration of retroviral DNA into the genome of the infected cell. Cancer Cells 1990; 2: 172-178.
5. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460-6464.
6. Dunbar CE, Emmons RV. Gene transfer into hematopoietic progenitor and stem cells: progress and problems. Stem Cells 1994; 12: 563-576.
7. Nienhuis AW. Gene transfer into hematopoietic stem cells. Blood Cells 1994; 20: 141-147.
8. Bodme DM, McDonagh KT, Seidel NE, Nienhuis AW. Development of a high-titer retrovirus producer cell line and strategies for retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells. Ann NY Acad Sci 1990; 612: 415-426.
9. Bunnell BA et al. High-efficiency retrovirus-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 1995; 92: 7739-7743.
10. Kotani H et al. Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 1994; 5: 19-28.
11. Paul RW et al. Increased viral titer through concentration of viral harvests from retroviral packaging lines. Hum Gene Ther 1993; 4: 609-615.
12. Wirth M, Grannemann R, Klehr D, Hauser H. Screening retroviral packaging cells for highly efficient virus production by using a combined selection procedure. J Virol 1994, 68: 566-569.
13. Strebel K, Klimkait T, Martin MA. A novel gene of HIV-1, Vpu, and its 16-kilodalton product. Science 1988; 241: 1221-1223.
14. Terwilliger EF et al. Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci USA 1989; 86: 5163-5167.
15. Yao XJ, Göttlinger H, Haseltine WA, Cohen EA. Envelope glycoprotein and CD4 independence of vpu-facilitated HIV-1 capsid export. J Virol 1992; 66: 5119-5126.
16. Gottlinger HG, Dorfman T, Cohen EA, Haseltine WA. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc Natl Acad Sci USA 1993; 90: 7381-7385.
17. Peterson A, Seed E. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988; 54: 65-72.
18. Peterson A. Genetic analysis of CD2/LFA3 and CD4/HIV interactions. PhD. thesis, Harvard University, Boston, MA, USA, 1988.
19. Miller DA, Law MF, Verma IM. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol Cell Biol 1985; 5: 431-07.
20. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
21. Cullen BR. Use of eukaryotic expression technology in the functional analysis of cloned genes. Meth Enzymol 1987; 152: 684-704.
22. Friborg J et al Mutational analysis of the HIV-1 Vpu protein. Leukemia 1994; 8: 156-162.
23. Cohen EA, Terwilliger EF, Sodroski JG, Haseltine WA. Identification of a protein encoded by the vpu gene of HIV-1. Nature 1988; 334: 532-534.
24. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587-3596.
25. Sakai H, Tokunaga K, Kawamura M, Adachi A. Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J Gen Virol 1995; 76: 2717-2722.
26. Yao XJ et al. The effect of vpu on HIV-1-induced syncytia formation. J Acq Imm Def Syn 1993; 6: 135-141.
27. Vogan K et al. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 1993; 53: 5269-5273.
28. Fort P, Marty L, Blanchard J. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 1985; 13: 1431-1442.
29. Treco D. Preparation of genomic DNA In: Ausubel F, Brent R (eds). Current Protocols in Molecular Biology. John Wiley: Brooklyn, NY, USA 1989, pp 292-299.
30. Goff S, Traktman P, Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol 1981; 38: 239-248.